依普利酮在中国上市了吗?
It is a selective aldosterone receptor antagonist, which only acts on mineralocorticoid receptors and does not act on androgen and progesterone receptors, and has fewer side effects. In treating patients with stage 1 and 2 hypertension, eplerenone has similar efficacy rates and reductions in systolic and diastolic blood pressure as enalapril. So, has India’s Lupine Pharmaceuticals’ eplerenone been launched in China?
Lupine Limited is an Indian multinational pharmaceutical company. Eplerenone has not yet been launched in China, and there is no medical insurance. Planep 50mg*100 tablets are priced at about $500 per box.
In 2002, eplerenone was approved for clinical use by the State Food and Drug Administration, but it has not been marketed in China, so Chinese patients cannot currently buy this drug in domestic pharmacies. Patients in need of eplerenone can purchase eplerenone abroad or obtain the drug through domestic professional overseas medical service organizations (such as Medical Companion Travel), which can be delivered directly to their homes to ensure authenticity.
In a study of systolic hypertension in the elderly, 269 patients were treated with eplerenone (50-200) mg daily and amlodipine (2.5-10) mg daily. The results showed that both drugs had the same effect in lowering systolic blood pressure, while amlodipine lowered diastolic blood pressure more significantly. In terms of target organ protection, both drugs improved carotid-femoral and carotid-radial pulse rates after 24 weeks of treatment.
In terms of the incidence of adverse reactions, 19.9% of the amlodipine group developed peripheral edema, while only 2.7% of the eplerenone group developed hyperkalemia. 0.4% of the amlodipine group developed hyperkalemia, and 0.9% of the eplerenone group developed hyperkalemia.
It is the first selective aldosterone receptor antagonist and has been used to treat hypertension and left ventricular dysfunction after acute myocardial infarction. It can effectively lower blood pressure, improve cardiac function and reduce myocardial damage.
Related hot article recommendations: /newsDetail/89977.html[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)